Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Panadol Extra gets an Advance

GSK Consumer Healthcare is set to launch Panadol Extra Advance, which will see ‘Optizorb’ technology added to the combined paracetamol and caffeine tablet.

GSK Consumer Healthcare is set to launch Panadol Extra Advance, which will see ‘Optizorb' technology added to the combined paracetamol and caffeine tablet.  

The launch this month will be supported by a television campaign in May, plus outdoor advertising and digital partnership work with MSN.

The product will replace Panadol Extra, and will be available in GSL packs of 8 (not available in pharmacy) and 14, and a P-pack of 32.

The Optizorb technology offers a faster rate of absorption, getting to work in as little as 10 minutes, according to the company.

Prices: £2.39/14; £4.00/32 Pip codes: 360-1531; 360-1549 GSK Consumer Healthcare Tel: 0845 762 6637         www.mypharmassist.co.uk   


Market focus

  • Headache and back pain are the most common forms of pain experienced.
  • 23 per cent of people experience pain every day, or have ongoing pain.
  • 14 per cent of people experience pain once a month.

Source: MM03-236 Segmentation UK Specific Report

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel